For instance, PET probes could not only be used for early detection of EGFR-positive tumor recurrence and stratification of cancer patients, but also for dose optimization of EGFR-TKIs therapy by monitoring the efficacy of EGFR-based tumor treatments. This evidence concerns the gene EGFR and neoplasm.